Olgotrelvir for COVID-19
1 study with >1,000 patients
Hospital Icon Control Serious Outcome Risk
Hospital Icon Olgotrelvir
Significantly lower risk for recovery.
COVID-19 Olgotrelvir studies. Dec 2025. c19early.org
0 0.5 1 1.5+ All studies 67% Hospitalization 67% RCTs 67% Early 67% Favorsolgotrelvir Favorscontrol
Recent:
Jiang.
May 28
2024
Jiang et al., NEJM Evidence, doi:10.1056/EVIDoa2400026 Olgotrelvir as a Single-Agent Treatment of Nonhospitalized Patients with Covid-19
22% improved recovery (p=0.0001). RCT 1,212 outpatients with mild to moderate COVID-19 showing faster recovery with olgotrelvir.